(-)-trans-CBD, (-)-trans-Cannabidiol (Canapure® PH)
At the CPhI in Frankfurt 2019, Symrise presented a high-profile new development: Canapure® PH. The cannabinoid is proven to be identical to the CBD in nature and complies with the guidelines of Good Manufacturing Practice (GMP), that set the rules for the good manufacture of medicines such as hygiene or control requirements. Canapure® PH serves both as a valuable pharmaceutical active substance and as an intermediate for new substances.
689383 Canapure® PH
GMP-certified nature-identical CBD ((-)-trans-cannabidiol) produced according to our proprietary process. Compliant with ICHQ7 and related laws in EU and US as well as with DAC monography (C-052). Backwards integrated raw material base. Year-round availability with consistent quality. It meets consumers expectations concerning no pesticides, no herbicides and other unwanted impurities.
Origin: chemical synthesis, identical to natural (-)-trans Cannabidiol
Min assay: 98,0 %
THC content: below detection limit
Melting point: 65-69 °C
Appearance 20 °C: white to pale yellow solid
Stability min: 3 years
Standard packaging: 1 kg and 5 kg drum
Please contact us for a detailed specification.